[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pelvic-floor-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pelvic-floor-disorder":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,49,83,104,146,176,212,242,264],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100634821","poly-l-lactic-acid-for-vulvovaginal-tissue-regeneration-100634821",false,"NCT07544667","Poly-L-Lactic Acid for Vulvovaginal Tissue Regeneration","Intravaginal Injection of Poly-L-Lactic Acid for Treatment of Cystocele: A Randomized Trial","Inclusion Criteria:\n\n* Age \\> 21\n* Stage II POP of anterior vaginal wall (Ba ≥ -1)\n* Symptomatic bulge symptoms\n\n  * Positive response to PFDI-20 question 3: Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?\n  * AND any degree of bother. Providing any answer other than \"not at all\" to \"how much does this bother you\"\n* Abstinent, on contraception, or postmenopausal at time of injection\n* Must read or understand English\n\nExclusion Criteria:\n\n* Concurrent apical or posterior prolapse \\> stage 1\n* Prior pelvic radiation\n* Previous vaginal reconstructive surgery (Except total vaginal hysterectomy or sling)\n* History of chronic vaginal infections (ex. Sexually transmitted infection or bacterial vaginosis)\n* Prior vaginal laser treatment \\\u003C 6 months\n* Planned vaginal laser\u002Ftopical treatment\n* History of hypertrophic reaction to vicryl (polyglactin-910)\n* Allergy to Sculptra aesthetic or any components of Sculptra (PLLA, carboxymethylcellulose, non-pyrogenic mannitol)\n* Allergy to silicone\n* Premenopausal without contraception or abstinence during treatment phase\n* Currently breastfeeding\n* Connective tissue disorder\n* Uncontrolled diabetes (defined as HbA1c \\> 8)\n* Does not read or understand English\n* Inability to provide informed consent\n* Physical limitations that would prevent subjects from performing the required pelvic wand massage sessions after each injection, such as significant arthritis or other mobility limitations.\n* Prescription anticoagulation therapy that cannot be safely discontinued (Aspirin and anti-platelet therapies would be considered acceptable)\n* Current use of other treatments for prolapse, such as pessary, in subjects who are unwilling to discontinue these treatments during the study period.\n* Planning to start pelvic floor physical therapy during the study\n* Undergoing physical therapy and not willing to stop internal therapy for 2 weeks after an injection or biopsy","FEMALE","21 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","Pelvic organ prolapse (POP) is a condition characterized by descent of vaginal walls, uterus and cervix, or the perineum and causes a sensation of vaginal bulge and pelvic pressure. Millions of women in the United States are affected, and the number is expected to rise significantly in the coming decades. Current treatments either involve conservative measures or surgery. Surgery may lead to changes in vaginal topography and scar tissue, both of which impact sexual function. There are no treatment options that restore vaginal tissue strength and preserve, even optimize, sensation and blood flow to the vagina. This project will evaluate the use of poly-L-lactic acid (PLLA), an FDA-approved biostimulant for dermatologic use with an expansive safety profile over the past decade, in the treatment of anterior wall POP and its impact on sexual function. Our study will compare intravaginal injection of PLLA vs. placebo in women with stage 2 cystocele and investigate safety and preliminary efficacy of PLLA. Prior study of regenerative biologics for the vulva and vagina have shown great promise, but use of these has not been explored for POP. This randomized controlled trial has the potential to shift the paradigm of prolapse management from surgical reconstruction to regeneration. This shift will prevent the risks of surgery and has the potential to improve sexual function and quality of life by resolving POP.",[26,27,28],"Pelvic Organ Prolapse (POP)","Cystocele","Pelvic Floor Disorder",[30,31,32,33,34,35],"regenerative medicine","biostimulant","tissue regeneration","pelvic floor disorder","pelvic organ prolapse","cystocele","NOT_YET_RECRUITING","2026-06-02",{"date":39,"type":40},"2026-06-04","ACTUAL",{"date":42,"type":20},"2026-07",{"date":44,"type":20},"2028-06",{"name":46,"class":47},"Cassandra Kisby","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":21,"phases":59,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":82},"100577439","reducing-disparities-in-urinary-control-symptoms-for-minority-women-100577439","NCT06798311","Reducing Disparities in Urinary Control Symptoms for Minority Women","SUPPORT","Inclusion Criteria:\n\n* Age 18 years or older\n* Able to converse in English\n* A response of at least \"somewhat bothered\" by urinary incontinence, urinary frequency or urgency on the UDI\n* Willing to engage in conservative treatment of their UI\u002FLUTS for 16 weeks\n\nExclusion Criteria:\n\n* Anterior or posterior pelvic organ prolapse beyond the hymen or apical prolapse to the hymen\n* Currently taking medications for their UI\u002FLUTS or history of surgical intervention for UI\n* Patients with abnormal PVR and positive urine culture at time of study entry\n* History of recurrent UTIs\n* History of mobility or neurologic disorders that would prevent ability to complete at home physical therapy\n* Planning to start PT within the next 16 weeks","18 Years",{"count":58,"type":20},80,[23],"The study is designed to address the disparity in available conservative\u002Fbehavioral treatments for UI\u002FLUTS. The program was developed by experts from urogynecology, psychology, and physical therapy then modified based on focus group feedback from racially minoritized women. The study team created a patient-centered, culturally adapted, self-directed, 8-week, home-based module for women with LUTS\u002FUI. The SUPPORT program combines multiple evidence-based conservative treatments for LUTS\u002FUI including cognitive behavioral therapy, behavioral modifications, and home physical therapy exercise. Progression through the home-based program is supported by research staff. This prospective interventional study aims to evaluate the feasibility and acceptability of the SUPPORT program and its impact on patient-centered treatment outcomes, while enabling comparisons across race and ethnicity. This approach will provide a comprehensive understanding of how to effectively deliver self-management strategies for pelvic floor disorders.\n\nAt the start of the 8 week SUPPORT course participants will also be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques and assisting patients in performing the SUPPORT exercises as outlined in the program. At the end of 8 weeks patients will fill out a survey assessing the frequency of use and interactions with the LLM.",[62,63,28],"Urinary Incontinence (UI)","Lower Urinary Tract Symptoms (LUTS)",[65,66,67,68,69,70,71],"cognitive behavioral therapy","self-directed","physical therapy","behavioral modifications","pelvic floor","home-based","health disparities","RECRUITING","2026-04-06",{"date":75,"type":40},"2026-04-07",{"date":77,"type":40},"2024-10-28",{"date":79,"type":20},"2027-05",{"name":81,"class":47},"University of Chicago",2,{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":90,"targetDuration":4,"studyType":21,"phases":91,"briefSummary":92,"conditions":93,"keywords":4,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":48},"100569103","video-based-pelvic-floor-muscle-therapy-100569103","NCT06689891","Video-Based Pelvic Floor Muscle Therapy","Utilizing Remote, Video-Based Pelvic Floor Muscle Therapy: A Feasibility Trial","Inclusion Criteria:\n\n* Diagnosis of pelvic floor dysfunction with referral for PFR\n* English-speaking\n\nExclusion Criteria:\n\n* Unable to access web-based videos\n* Unable to speak English",{"count":19,"type":20},[23],"This study is a feasibility, pilot trial of remote, video-based pelvic floor muscle therapy (PFMT) for patients with pelvic floor disorders, including pelvic organ prolapse, urinary incontinence and anorectal dysfunction. PFMT has been shown to improve these symptoms in multiple studies.",[28,94],"Pelvic Floor Muscle Exercise","2026-01-15",{"date":97,"type":40},"2026-01-16",{"date":99,"type":40},"2025-06-09",{"date":101,"type":20},"2026-12",{"name":103,"class":47},"Yale University",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":110,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":112,"targetDuration":4,"studyType":21,"phases":114,"briefSummary":115,"conditions":116,"keywords":125,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":48},"100610142","postpartum-education-via-artificial-intelligence-for-recovery-and-loneliness-a-randomized-controlled-trial-100610142","NCT07223736","Postpartum Education Via Artificial Intelligence for Recovery and Loneliness: A Randomized Controlled Trial","Postpartum Education Via Artificial Intelligence for Recovery and Loneliness (PEARL): A Randomized Controlled Trial","PEARL","Inclusion Criteria:\n\n1. Has the capacity to provide informed consent\n2. Stated willingness to comply with all study procedures and availability for the duration of the study\n3. Postpartum persons, aged \\>18 years old\n4. Primiparous\n5. Vaginal or cesarean delivery\n6. English Speaking\n7. Internet access and proficiency of internet access\n8. Access to a smartphone\n9. Postpartum 2-6 weeks\n\nExclusion Criteria:\n\n1. Multiparous\n2. Major neonatal anomaly\n3. Delivery \\\u003C 34 weeks gestational age\n4. Intrauterine fetal demise (IUFD)\n5. Enrollment in any interfering studies\n6. Unanticipated NICU admission\n7. Discharge home without live baby\n8. Surrogates\u002Fgestational carrier\n9. Birthing individuals with baby placed for adoption\n10. Currently pregnant\n11. Psychiatric history requiring psychiatric hospitalization prior to delivery\n12. Other psychiatric conditions needing immediate attention and intervention as determined by study team and\u002For treatment team",{"count":113,"type":20},130,[23],"The goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth.\n\nThe main questions this study aims to answer are:\n\n* Does using the chatbot improve postpartum pelvic floor health knowledge?\n* Does using the chatbot help reduce feelings of loneliness during the postpartum period?\n* Does using the chatbot impact pelvic floor symptoms?\n\nResearchers will compare standard postpartum care to standard care plus the chatbot.\n\nParticipants will:\n\nBe assigned by chance (like flipping a coin) to standard postpartum care with or without access to the chatbot.\n\nIf in the chatbot group, participants will receive education and support via the chatbot over a 4-week period.\n\nBoth groups will complete questionnaires to measure their pelvic floor knowledge, pelvic floor symptoms, feelings of loneliness, depression, infant bonding, perceived social support, adverse childhood experiences, and peri-traumatic distress.\n\nThe chatbot was created by urogynecology experts in collaboration with UC San Diego computer science and biomedical informatics researchers. The chatbot is designed to give new mothers personalized, evidence-based information and support in real time.",[28,117,118,119,120,121,122,123,124],"Loneliness","Postpartum","Mental Health","Depression","Peritraumatic Distress","Women","Artificial Intelligence (AI)","Chatbot",[126,127,33,128,129,130,131,132,133,134,135,136],"loneliness","postpartum","mental health","depression","peritraumatic distress","artificial intelligence","AI","chatbot","LLM","women","large language model","2025-10-31",{"date":139,"type":40},"2025-11-03",{"date":141,"type":20},"2025-11-10",{"date":143,"type":20},"2026-11-01",{"name":145,"class":47},"University of California, San Diego",{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":11,"sex":16,"minAge":153,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":21,"phases":157,"briefSummary":158,"conditions":159,"keywords":161,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":167,"lastUpdatePostDateStruct":168,"startDateStruct":170,"completionDateStruct":172,"leadSponsor":174,"locationsCount":48},"100598328","virtual-reality-for-urinary-incontinence-in-women-100598328","NCT07070063","Virtual Reality for Urinary Incontinence in Women","Use of Virtual Reality in the Treatment of Various Types of Urinary Incontinence in Women","Inclusion Criteria:\n\n* Women aged 50-80 years, who are at least 12 months post-menopausal,\n* Diagnosed with urinary incontinence of grade I or IIa according to the ICS classification,\n* No contraindications to participation (e.g., acute urinary tract infections, severe neurological disorders),\n* Provision of written informed consent to participate in the research experiment.\n\nExclusion Criteria:\n\n* Urinary incontinence of grade III or higher,\n* Presence of significant neurological conditions affecting bladder control,\n* Participation in other therapeutic interventions that could interfere with study outcomes,\n* Pregnancy,\n* Refusal or inability to provide informed consent.","50 Years","80 Years",{"count":156,"type":20},40,[23],"This study evaluates the effectiveness of using virtual reality to support pelvic floor muscle training in women with urinary incontinence. The intervention aims to enhance patients' motivation, awareness, and exercise accuracy through real-time muscle visualization and immersive interaction. The project seeks to determine whether virtual reality-assisted therapy improves clinical outcomes compared to conventional approaches.",[160,28],"Urinary Incontinence",[162,163,164,165,166],"Virtual Reality","Rehabilitation","Pelvic Floor Muscle Training","Urinary incontinence","Women's health","2025-07-22",{"date":169,"type":40},"2025-07-24",{"date":171,"type":40},"2025-07-15",{"date":173,"type":20},"2027-06-15",{"name":175,"class":47},"Wroclaw University of Health and Sport Sciences",{"id":177,"slug":178,"hasResults":11,"nctId":179,"briefTitle":180,"officialTitle":180,"acronym":4,"eligibilityCriteria":181,"healthyVolunteers":182,"sex":16,"minAge":17,"maxAge":183,"enrollmentInfo":184,"targetDuration":4,"studyType":21,"phases":186,"briefSummary":187,"conditions":188,"keywords":196,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":204,"lastUpdatePostDateStruct":205,"startDateStruct":206,"completionDateStruct":208,"leadSponsor":210,"locationsCount":48},"100597993","transperineal-ultrasound-as-a-biofeedback-tool-for-pelvic-floor-muscle-therapy-in-postpartum-patients-100597993","NCT07065708","Transperineal Ultrasound as a Biofeedback Tool for Pelvic Floor Muscle Therapy in Postpartum Patients","Inclusion Criteria:\n\n* Female participants\n* Aged 21 - 45 years old.\n* Within 4 months of a singleton, vaginal delivery\n\nExclusion Criteria:\n\n* Currently pregnant\n* Over 4 months since vaginal birth.\n* Previous caesarean delivery.\n* Previous pelvic floor surgery (eg. pelvic floor repair, continence surgery, cervicetomy,cosmetic pelvic floor procedures)\n* Neurological disorder affecting muscle contraction (eg. Guillan-Barre syndrome, motorneuron disease, multiple sclerosis)",true,"45 Years",{"count":185,"type":20},94,[23],"Regular and effective pelvic floor muscle exercises after vaginal birth are crucial in reducing the risk of pelvic floor disorders in women. Pelvic floor muscle exercises are generally encouraged by healthcare providers to their patients after birth. However, it is often difficult to confirm whether a patient is performing pelvic floor muscle contractions correctly. A supervised pelvic floor physiotherapy session allows a professional to assess the pelvic floor and give their verbal feedback to patients. However even in this setting, patient's are reliant on the physiotherapist and have no way to assess their own performance. The 'biofeedback approach' allows for the clinician and patient to visually assess and modify their performance and can potentially allow for more effective therapy and better engagement. Transperineal ultrasonography is a widely available, safe and non-invasive biofeedback tool that can used at the bedside in order to assess pelvic floor muscle contractions. Our aim is to assess if using transperineal ultrasound can enhance the ability of postpartum patients to perform effective pelvic floor muscle therapy.",[164,189,190,118,28,94,191,192,193,194,195],"Transperineal Ultrasound","Biofeedback Therapy","Pelvic Floor, Obstetric","Pelvic Floor Dysfunction","Pelvic Floor Health After Childbirth","Physiotherapy","Physiotherapy Specialty",[197,198,199,200,201,202,33,203],"pelvic floor muscle training","biofeedback","transperineal ultrasound","pelvic floor exercises","physiotherapy","pelvic floor dysfunction","pelvic floor contraction","2025-07-03",{"date":171,"type":40},{"date":207,"type":40},"2025-05-20",{"date":209,"type":20},"2026-09",{"name":211,"class":47},"Singapore General Hospital",{"id":213,"slug":214,"hasResults":11,"nctId":215,"briefTitle":216,"officialTitle":217,"acronym":4,"eligibilityCriteria":218,"healthyVolunteers":11,"sex":219,"minAge":220,"maxAge":221,"enrollmentInfo":222,"targetDuration":4,"studyType":21,"phases":224,"briefSummary":225,"conditions":226,"keywords":228,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":233,"lastUpdatePostDateStruct":234,"startDateStruct":236,"completionDateStruct":238,"leadSponsor":240,"locationsCount":48},"100580540","redcord-in-neurogenic-bowel-dysfunction-in-multiple-sclerosis-100580540","NCT06838624","RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis","Effectiveness of Treatment With RedCord in Neurogenic Bowel Dysfunction in People With Multiple Sclerosis","Inclusion Criteria:\n\n* People diagnosed with Multiple Sclerosis according to McDonald's criteria.\n* EDSS less than 6 points.\n* Willingness to participate.\n\nExclusion Criteria:\n\n* People with cognitive impairment, which makes it difficult to understand the questionnaires properly.\n* Pregnant women.\n* Severe psychological or psychiatric pathology diagnosed.","ALL","30 Years","60 Years",{"count":223,"type":20},76,[23],"The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:\n\n* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients.\n* Compare the outcomes of Redcord treatment with standard care practices.\n\nParticipants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.",[227,28],"Multiple Sclerosis",[227,229,230,231,232],"Constipation","Faecal Incontinence","Pelvic Floor","Abdominal Muscles","2025-02-20",{"date":235,"type":40},"2025-02-24",{"date":237,"type":20},"2025-09-01",{"date":239,"type":20},"2026-12-15",{"name":241,"class":47},"University of Castilla-La Mancha",{"id":243,"slug":244,"hasResults":11,"nctId":245,"briefTitle":246,"officialTitle":246,"acronym":247,"eligibilityCriteria":248,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":249,"targetDuration":4,"studyType":251,"phases":4,"briefSummary":252,"conditions":253,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":255,"lastUpdatePostDateStruct":256,"startDateStruct":258,"completionDateStruct":260,"leadSponsor":262,"locationsCount":48},"100577363","evaluating-the-feasibility-of-a-web-app-for-pelvic-floor-health-in-pregnant-women-in-the-ferrol-health-area-the-wapruin-study-100577363","NCT06797323","Evaluating the Feasibility of a Web-App for Pelvic Floor Health in Pregnant Women in the Ferrol Health Area: the WaPRUIN Study","WaPRUIN","Inclusion Criteria:\n\n* Pregnant women attending their first prenatal consultation at the Hospital Arquitecto Marcide.\n* Pregnant women who voluntarily consent to participate in the study by signing the informed consent form.\n\nExclusion Criteria:\n\n* Pregnant women who do not have proficiency in the Spanish language.\n* Limitations in using the web-app (e.g., physical, cognitive, or technological barriers).\n* Lack of internet access.",{"count":250,"type":20},212,"OBSERVATIONAL","This study aims to evaluate the feasibility of using a web-based application to improve pelvic floor health in pregnant women within the Ferrol Health Area, Spain. The intervention involves providing educational resources through a user-friendly digital platform, designed to empower women with knowledge about pelvic floor function and techniques for strengthening it during pregnancy.\n\nThe study hypothesizes that a web-based educational tool can effectively increase awareness, engagement, and adherence to pelvic floor exercises among pregnant women, thereby contributing to improved maternal health outcomes. Participants will include pregnant women from the Ferrol Health Area, who will voluntarily use the application during their pregnancy.\n\nThe study will assess outcomes related to usability, accessibility, and participant satisfaction with the application, as well as any improvements in pelvic floor-related health indicators. By addressing an important gap in maternal health education, this project has the potential to provide an innovative and scalable solution to enhance prenatal care.",[254,28],"Pregnancy","2025-01-22",{"date":257,"type":40},"2025-01-28",{"date":259,"type":20},"2025-03-10",{"date":261,"type":20},"2025-11",{"name":263,"class":47},"Universidad de Oviedo",{"id":265,"slug":266,"hasResults":11,"nctId":267,"briefTitle":268,"officialTitle":269,"acronym":4,"eligibilityCriteria":270,"healthyVolunteers":182,"sex":16,"minAge":56,"maxAge":271,"enrollmentInfo":272,"targetDuration":274,"studyType":251,"phases":4,"briefSummary":268,"conditions":275,"keywords":278,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":282,"lastUpdatePostDateStruct":283,"startDateStruct":285,"completionDateStruct":287,"leadSponsor":289,"locationsCount":4},"100575216","relationship-between-pelvic-floor-dysfunctions-and-sexual-dysfunction-in-female-patients-with-systemic-sclerosis-100575216","NCT06769399","Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis","Investigation of the Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis: a Cross-Sectional Study","Inclusion Criteria:\n\n* female gender\n* being between 18-64 years old\n* having a diagnosis of systemic sclerosis (SSc)\n* being sexually active, and not having entered menopause\n\nThe control group will consist of healthy women aged 18-64 years who are sexually active, have not entered menopause, have no history of urological or gynecological surgeries other than cesarean section, and have no rheumatologic or severe chronic diseases.\n\nExclusion Criteria:\n\n* the presence of current or past rheumatologic diseases other than SSc\n* the presence of current urogynecological diseases\n* a history of urological or gynecological surgeries other than cesarean section.","64 Years",{"count":273,"type":20},140,"1 Day",[276,277,28],"Systemic Sclerosis (SSc)","Sexual Dysfunctions",[279,280,281],"systemic sclerosis","female sexual dysfunction","pelvic floor disorders","2025-01-09",{"date":284,"type":40},"2025-01-10",{"date":286,"type":20},"2025-01-15",{"date":288,"type":20},"2025-05-15",{"name":290,"class":47},"Istanbul University - Cerrahpasa"]